128 related articles for article (PubMed ID: 33656221)
21. Patterns of increased incidence and survival of cutaneous melanoma in Girona (Spain) 1994-2013: a population-based study.
Rubió-Casadevall J; Puig-Vives M; Puigdemont M; Vilardell L; Carbó-Bagué A; Marcos-Gragera R; Vilar-Coromina N
Clin Transl Oncol; 2018 Dec; 20(12):1617-1625. PubMed ID: 29873027
[TBL] [Abstract][Full Text] [Related]
22. Cancer in adolescents and young adults (15-29 years): a population-based study in the Netherlands 1989-2009.
Aben KK; van Gaal C; van Gils NA; van der Graaf WT; Zielhuis GA
Acta Oncol; 2012 Sep; 51(7):922-33. PubMed ID: 22934554
[TBL] [Abstract][Full Text] [Related]
23. Sex matters: men with melanoma have a worse prognosis than women.
El Sharouni MA; Witkamp AJ; Sigurdsson V; van Diest PJ; Louwman MWJ; Kukutsch NA
J Eur Acad Dermatol Venereol; 2019 Nov; 33(11):2062-2067. PubMed ID: 31246315
[TBL] [Abstract][Full Text] [Related]
24. Trends of cutaneous squamous cell carcinoma in the Netherlands: increased incidence rates, but stable relative survival and mortality 1989-2008.
Hollestein LM; de Vries E; Nijsten T
Eur J Cancer; 2012 Sep; 48(13):2046-53. PubMed ID: 22342554
[TBL] [Abstract][Full Text] [Related]
25. Melanoma in older patients: declining gap in survival between younger and older patients with melanoma.
Schuurman MS; Hollestein LM; Bastiaannet E; Posthuma EFM; van Akkooi AJC; Kukutsch NA; Aarts MJB; Wakkee M; Lemmens VEPP; Louwman MWJ
Acta Oncol; 2020 Jan; 59(1):4-12. PubMed ID: 31347929
[No Abstract] [Full Text] [Related]
26. Trends in the survival of patients diagnosed with malignant melanoma of the skin in the Nordic countries 1964-2003 followed up to the end of 2006.
Tryggvadóttir L; Gislum M; Hakulinen T; Klint A; Engholm G; Storm HH; Bray F
Acta Oncol; 2010 Jun; 49(5):665-72. PubMed ID: 20491525
[TBL] [Abstract][Full Text] [Related]
27. [Revision of the national guideline 'Melanoma'].
Veerbeek L; Kruit WH; de Wilt J; Mooi WJ; Bergman W;
Ned Tijdschr Geneeskd; 2013; 157(12):A6136. PubMed ID: 23515047
[TBL] [Abstract][Full Text] [Related]
28. Recent trends in cutaneous malignant melanoma in the Yorkshire region of England; incidence, mortality and survival in relation to stage of disease, 1993-2003.
Downing A; Newton-Bishop JA; Forman D
Br J Cancer; 2006 Jul; 95(1):91-5. PubMed ID: 16755289
[TBL] [Abstract][Full Text] [Related]
29. Risks of different skin tumour combinations after a first melanoma, squamous cell carcinoma and basal cell carcinoma in Dutch population-based cohorts: 1989-2009.
van der Leest RJT; Hollestein LM; Liu L; Nijsten T; de Vries E
J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):382-389. PubMed ID: 28898461
[TBL] [Abstract][Full Text] [Related]
30. Population-based incidence and melanoma-specific survival of cutaneous malignant melanoma in a Colombian population 2000-2009.
Reyes E; Uribe C; de Vries E
Int J Dermatol; 2018 Jan; 57(1):21-27. PubMed ID: 29231241
[TBL] [Abstract][Full Text] [Related]
31. A profile of invasive cutaneous malignant melanoma in Malta: 1993-2002.
Aquilina S; Dalmas M; Calleja N; Gatt P; Scerri L
J Eur Acad Dermatol Venereol; 2006 Sep; 20(8):958-63. PubMed ID: 16922945
[TBL] [Abstract][Full Text] [Related]
32. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study.
Spanogle JP; Clarke CA; Aroner S; Swetter SM
J Am Acad Dermatol; 2010 May; 62(5):757-67. PubMed ID: 20223559
[TBL] [Abstract][Full Text] [Related]
33. Epidemiology of basal and squamous cell carcinoma in Belgium: the need for a uniform and compulsory registration.
Callens J; Van Eycken L; Henau K; Garmyn M
J Eur Acad Dermatol Venereol; 2016 Nov; 30(11):1912-1918. PubMed ID: 27256411
[TBL] [Abstract][Full Text] [Related]
34. Under-registration of melanoma in Belgium: an analysis.
Brochez L; Verhaeghe E; Bleyen L; Myny K; De Backer G; Naeyaert JM
Melanoma Res; 1999 Aug; 9(4):413-8. PubMed ID: 10504062
[TBL] [Abstract][Full Text] [Related]
35. Predictions of skin cancer incidence in the Netherlands up to 2015.
de Vries E; van de Poll-Franse LV; Louwman WJ; de Gruijl FR; Coebergh JW
Br J Dermatol; 2005 Mar; 152(3):481-8. PubMed ID: 15787817
[TBL] [Abstract][Full Text] [Related]
36. Increasing time trends of thin melanomas in The Netherlands: What are the explanations of recent accelerations?
van der Leest RJ; Zoutendijk J; Nijsten T; Mooi WJ; van der Rhee JI; de Vries E; Hollestein LM
Eur J Cancer; 2015 Dec; 51(18):2833-41. PubMed ID: 26589973
[TBL] [Abstract][Full Text] [Related]
37. Sex differences in rising trends of cutaneous malignant melanoma in Norway, 1954-2008.
Robsahm TE; Bergva G; Hestvik UE; Møller B
Melanoma Res; 2013 Feb; 23(1):70-8. PubMed ID: 23222548
[TBL] [Abstract][Full Text] [Related]
38. Rare vulvar malignancies; incidence, treatment and survival in the Netherlands.
Pleunis N; Schuurman MS; Van Rossum MM; Bulten J; Massuger LF; De Hullu JA; Van der Aa MA
Gynecol Oncol; 2016 Sep; 142(3):440-5. PubMed ID: 27126004
[TBL] [Abstract][Full Text] [Related]
39. Epidemiology of cutaneous melanoma and melanoma in situ: a 10-year nationwide retrospective cohort study in South Korea.
Soh BW; Kim YC; Choi JW
Melanoma Res; 2020 Jun; 30(3):297-302. PubMed ID: 32356958
[TBL] [Abstract][Full Text] [Related]
40. Epidemiology, management and survival outcomes of primary cutaneous melanoma: a ten-year overview.
Aubuchon MM; Bolt LJ; Janssen-Heijnen ML; Verleisdonk-Bolhaar ST; van Marion A; van Berlo CL
Acta Chir Belg; 2017 Feb; 117(1):29-35. PubMed ID: 27774842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
